These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35890379)

  • 1. Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study.
    Hassan DH; Shohdy JN; El-Setouhy DA; El-Nabarawi M; Naguib MJ
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization,
    Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA
    Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations.
    Unnisa A; Chettupalli AK; Alazragi RS; Alelwani W; Bannunah AM; Barnawi J; Amarachinta PR; Jandrajupalli SB; Elamine BA; Mohamed OA; Hussain T
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
    Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
    BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation,
    Taha E; Nour SA; Mamdouh W; Selim AA; Swidan MM; Ibrahim AB; Naguib MJ
    Int J Pharm X; 2023 Dec; 5():100160. PubMed ID: 36647457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation.
    Patil K; Gujarathi N; Sharma C; Ojha S; Goyal S; Agrawal Y
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers.
    Raval S; Jani P; Patil P; Thakkar P; Sawant K
    Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.
    Bhatt S; Sharma JB; Kamboj R; Kumar M; Saini V; Mandge S
    Turk J Pharm Sci; 2021 Feb; 18(1):61-67. PubMed ID: 33633486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
    Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
    AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured Etodolac Carriers in Transdermal Gel: Optimization and Characterization.
    Patil P; Shirkhedkar A
    Pharm Nanotechnol; 2023 Jun; 11(3):276-293. PubMed ID: 36635925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study.
    El Assasy AEI; Younes NF; Makhlouf AIA
    AAPS PharmSciTech; 2019 Jan; 20(2):82. PubMed ID: 30652198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
    Awadeen RH; Boughdady MF; Meshali MM
    Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic development and characterization of curcumin-loaded nanogel for topical application.
    Kesharwani P; Jain A; Srivastava AK; Keshari MK
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1443-1457. PubMed ID: 32644836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.